Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Companies to Partner on Sustainable Synthetic Biochemicals

Iowa cornfield

A producer of plant-based organic acids and a developer of synthetic bio-based materials and services are partnering on new sustainable industrial chemicals. . . . → Read More: Companies to Partner on Sustainable Synthetic Biochemicals

Neurons Identified, Stimulated for Spinal Cord Repair

Spine

Spinal cord injury patients in a clinical trial received electronic stimulation to a specified set of nerve cells that enabled them to restore walking after rehabilitation. . . . → Read More: Neurons Identified, Stimulated for Spinal Cord Repair

Patent Awarded for Focused Ultrasound Skin Treatments

U.S. Patent and Trademark Office

A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology. . . . → Read More: Patent Awarded for Focused Ultrasound Skin Treatments

Covid-19 Vaccine Patch Clinical Trial Begins

Vaccine patch

Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins

Trial Shows Results for Personal Cancer Immunotherapies

DNA plasmid illustration

Interim results from a clinical trial testing personalized therapies invoking the immune system show responses from some patients with advanced liver cancer. . . . → Read More: Trial Shows Results for Personal Cancer Immunotherapies

AI-Aided System to Identify Diabetes Complication Risks

Diabetes blood glucose test

Researchers at University of Houston are creating a system aided by algorithms for primary care physicians to better identify people at risk for complications from diabetes. . . . → Read More: AI-Aided System to Identify Diabetes Complication Risks

Cancer Detection Start-Up Gains $4M in Seed Funds

Detect cancer scrabble

A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round. . . . → Read More: Cancer Detection Start-Up Gains $4M in Seed Funds

RSV Nose Drops Vaccine Gets FDA Fast Track Tag

Respiratory syncytial virus

A vaccine designed from engineered live viruses and taken as nose drops to prevent respiratory syncytial virus received a Food and Drug Administration fast-track designation. . . . → Read More: RSV Nose Drops Vaccine Gets FDA Fast Track Tag

Gut-Brain Meds Developer Going Public in Merger

Milk splashing

(Myriams-Fotos, Pixabay. https://pixabay.com/photos/milk-splash-drops-food-liquid-4755234/)

31 Oct. 2022. A developer of synthetic biology treatments for inflammatory and neurological disorders linked to the gut is becoming a public company through a special acquisition merger. Intrinsic Medicine Inc. in Seattle is joining with Phoenix Biotech Acquisition Corp. in Oakland, California, a special purpose acquisition company or SPAC, . . . → Read More: Gut-Brain Meds Developer Going Public in Merger

Infographic – US Public Supports Govt Science Spending

Chart: U.S. trust in science

Most Americans believe the U.S. should be the world leader in scientific achievement, and support continued U.S. government investments in science. . . . → Read More: Infographic – US Public Supports Govt Science Spending